| Scorecard |
|---|
|
5 / 5 Stars
|
|
Lipper
5
5
4
5
1
|
|
Zacks Investment Research
2
(Buy)
|
|
Standard & Poor's
5 / 5 Stars
|
|
TheStreet.com
A-
(Buy)
|
U.S. News evaluated 77 Foreign Large Growth Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.
Performance
The fund has returned 29.58 percent over the past year, 15.46 percent over the past three years, 1.52 percent over the past five years, and 9.28 percent over the past decade.
| Trailing Returns | Updated 05.31.2013 |
|---|---|
| Year to date | 8.3% |
| 1 Year | 29.6% |
| 3 Years (Annualized) | 15.5% |
| 5 Years (Annualized) | 1.5% |
| 10 Years (Annualized) | 9.3% |
Summary
The investment seeks high total return. The fund's manager seeks to achieve the fund's investment objective by investing primarily in a portfolio of equity securities that the Manager believes will provide a higher return than the MSCI EAFE Growth Index. It normally invests directly and indirectly at least 80% of its assets in equity investments (see "Name Policies").
Fees
Fees are Low compared to funds in the same category.
GMO International Growth Equity Fund has an expense ratio of 0.59 percent.
Risk
Risk is Below Average compared to funds in the same category according to Morningstar.
